Sacrococcygeal teratoma pathophysiology

Revision as of 16:07, 21 December 2015 by Mirdula Sharma (talk | contribs)
Jump to navigation Jump to search

Sacrococcygeal teratoma Microchapters

Home

Patient Information

Overview

Historical perspective

Classification

Pathophysiology

Causes

Differentiating Sacrococcygeal teratoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural history, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History & Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Sacrococcygeal teratoma pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Sacrococcygeal teratoma pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Sacrococcygeal teratoma pathophysiology

CDC on Sacrococcygeal teratoma pathophysiology

Sacrococcygeal teratoma pathophysiology in the news

Blogs on Sacrococcygeal teratoma pathophysiology

Directions to Hospitals Treating Sacrococcygeal teratoma

Risk calculators and risk factors for Sacrococcygeal teratoma pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Mirdula Sharma, MBBS [2]

Overview

Pathogenesis

Sacrococcygeal teratomas originate from the pluripotent cells in primitive knot or Hensen's node, which is the primary organizer of embryonic development, located on the anterior surface of the sacrum or coccyx.[1]

Genetics

Development of Sacrococcygeal teratoma is associated with gain of gain of chromosomes 1q32-qter regions and losses of the 6q24-qter and 18q21-qter regions.[2][3]

Associated Conditions

Following conditions are associated with:

  • Bladder outlet obstruction
  • Hydronephrosis
  • Rectal stenosis or atresia
  • Hydrops fetalis
  • Cardiomegaly due to vascular shunting and high output cardiac failure

Gross Pathology

Microscopic Pathology

  • Sacrococcygeal teratoma can be divided into three types depending on the microscopic pathology, as follow:
  • Mature teratoma:may consist of fully differentiated somatic tissue.[4]
  • Immature teratoma: may consist of small fraction of incompletely differentiated tissue.
  • Malignant teratoma:
  • Around 20% of Sacrococcygeal teratomas are malignant.
  • They have elevated tumor markers including yolk sac component secreting alpha fetoprotein or primitive neuroectodermal tumor (PNET).

Grading Based Upon Microscopic Features

According to Gonzalez-Crussi System, Sacrococcygeal teratoma is graded on a scale from 0-3, based on the histology:[5][6]

Grade Microscopic Features

Grade 0

  • Tumor contains only mature tissue

Grade I

  • Tumor contains rare foci of immature tissues
  • Less than 10% tissue is Immature

Grade II

  • Tumor contains moderate quantities of immature tissues.
  • Upto 10-50% tissue in immature

Grade III

  • Tumor contains large quantities of immature tissue with or without malignant yolk sac elements.
  • More than 50% tissue is immature

References

  1. http://www.hindawi.com/journals/criog/2012/131369/
  2. Harms D, Zahn S, Göbel U, Schneider DT (2006). "Pathology and molecular biology of teratomas in childhood and adolescence". Klin Padiatr. 218 (6): 296–302. doi:10.1055/s-2006-942271. PMID 17080330.
  3. Veltman I, Veltman J, Janssen I, Hulsbergen-van de Kaa C, Oosterhuis W, Schneider D, Stoop H, Gillis A, Zahn S, Looijenga L, Göbel U, van Kessel AG (2005). "Identification of recurrent chromosomal aberrations in germ cell tumors of neonates and infants using genomewide array-based comparative genomic hybridization". Genes Chromosomes Cancer. 43 (4): 367–76. doi:10.1002/gcc.20208. PMID 15880464.
  4. Calaminus G, Schneider DT, Bökkerink JP, Gadner H, Harms D, Willers R, Göbel U (2003). "Prognostic value of tumor size, metastases, extension into bone, and increased tumor marker in children with malignant sacrococcygeal germ cell tumors: a prospective evaluation of 71 patients treated in the German cooperative protocols Maligne Keimzelltumoren (MAKEI) 83/86 and MAKEI 89". J. Clin. Oncol. 21 (5): 781–6. PMID 12610174.
  5. Myers LB, Bulich LA. Anesthesia for Fetal Intervention and Surgery. PMPH-USA; 2005.
  6. Harms D, Zahn S, Göbel U, Schneider DT (2006). "Pathology and molecular biology of teratomas in childhood and adolescence". Klin Padiatr. 218 (6): 296–302. doi:10.1055/s-2006-942271. PMID 17080330.

Template:WH Template:WS

Template:WikiDoc Sources